Conserving resources in the diagnosis of intraoral fibroepithelial polyps

Br J Oral Maxillofac Surg. 2021 Jan;59(1):e9-e12. doi: 10.1016/j.bjoms.2020.05.025. Epub 2020 Jun 6.

Abstract

Fibroepithelial polyps (FEPs) are common, benign intraoral lesions that tend to develop slowly at predictable sites, often in response to local irritation or trauma. Historical precedent often results in referral to oral and maxillofacial surgery (OMFS) departments for biopsy, often irrespective of symptoms, and histological assessment. OMFS and pathology services are struggling to cope with an increasing workload that will potentially lead to widespread delays to diagnosis and treatment. Over the past 20 years, clinical pathways and guidance have been developed to ensure that healthcare interventions, such as the removal of third molars, tonsils, skin tags, and benign moles, are evidence-based, have a net patient benefit, and ensure the best use of finite NHS resources. However, no such guidance exists for intraoral lesions and we regard this as an oversight. We analysed the removal of 682 FEPs over a seven-year period and report sensitivities of 92.4% for a "confirmed clinical suspicion of an FEP" and 99.7% for a "confirmed clinical suspicion of a benign diagnosis". The incidence of non-benign disease was 0.3%. Primary care dentists should be able to diagnose and monitor FEPs and refer only if symptoms are serious or in high-risk patients or sites. Adopting this practice across the UK could free up to 1825 four-hour OMFS clinics, 405hours of consultant histopathologists' time, and recurring savings to the NHS estimated to be in the region of £620 000/annum. We believe that the removal of FEPs should be reclassified as an "intervention not normally funded", and the time and resources put to better use treating patients with lesions of questionable pathology.

Keywords: Fibro-epithelial polyps; NHS resources; diagnostic yield; individual funding request; intervention not normally funded; unnecessary histology requests.

MeSH terms

  • Carcinoma, Squamous Cell*
  • Humans
  • Neoplasm Recurrence, Local
  • Polyps* / diagnosis
  • Polyps* / surgery
  • Skin Diseases*
  • Skin Neoplasms*